Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection.
about
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune responseOral bacillus Calmette-Guérin vaccine against tuberculosis: why not?The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles).
P2860
Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@ast
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@en
type
label
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@ast
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@en
prefLabel
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@ast
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@en
P2093
P1476
Immunogenicity of orally-deliv ...... terium tuberculosis infection.
@en
P2093
Ann Williams
Frank E Aldwell
Julia Vipond
Martin L Cross
Matthew R Lambeth
Simon Clark
P304
P356
10.1016/J.MICINF.2008.09.004
P577
2008-09-23T00:00:00Z